Details of Protein
| General Information of Protein (ID: PRT01579) | |||||
|---|---|---|---|---|---|
| Name | Phosphoserine aminotransferase (PSAT1) | ||||
| Synonyms |
Click to Show/Hide Synonyms of This Protein
Phosphohydroxythreonine aminotransferase; PSAT; PSAT1; PSA
|
||||
| Gene Name | PSAT1 | Gene ID | |||
| UniProt ID | |||||
| Family | Transferases (EC 2) | ||||
| EC Number | EC: 2.6.1.52 (Click to Show/Hide the Complete EC Tree) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
| Sequence |
MDAPRQVVNFGPGPAKLPHSVLLEIQKELLDYKGVGISVLEMSHRSSDFAKIINNTENLV
RELLAVPDNYKVIFLQGGGCGQFSAVPLNLIGLKAGRCADYVVTGAWSAKAAEEAKKFGT INIVHPKLGSYTKIPDPSTWNLNPDASYVYYCANETVHGVEFDFIPDVKGAVLVCDMSSN FLSKPVDVSKFGVIFAGAQKNVGSAGVTVVIVRDDLLGFALRECPSVLEYKVQAGNSSLY NTPPCFSIYVMGLVLEWIKNNGGAAAMEKLSSIKSQTIYEIIDNSQGFYVCPVEPQNRSK MNIPFRIGNAKGDDALEKRFLDKALELNMLSLKGHRSVGGIRASLYNAVTIEDVQKLAAF MKKFLEMHQL |
||||
| Structure | |||||
| Function | Catalyzes the reversible conversion of 3-phosphohydroxypyruvate to phosphoserine and of 3-hydroxy-2-oxo-4-phosphonooxybutanoate to phosphohydroxythreonine. | ||||
| Regulatory Network | |||||
| Full List of Metabolite(s) Regulating This Protein | ||||||
|---|---|---|---|---|---|---|
| Organic acids and derivatives | ||||||
| Glutamine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Glutamine decrease (48 hours) | |||||
| Induced Change | PSAT1 protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Cervical Cancer [ICD-11: 2C77] ... | |||||
| Details | It is reported that glutamine decrease causes the increase of PSAT1 protein expression compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Glutamine decrease (48 hours) | |||||
| Induced Change | PSAT1 mRNA levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Cervical Cancer [ICD-11: 2C77] ... | |||||
| Details | It is reported that glutamine decrease causes the increase of PSAT1 mRNA levels compared with control group. | |||||
| Organic oxygen compounds | ||||||
| Glucose | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Glucose decrease (48 hours) | |||||
| Induced Change | PSAT1 protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Cervical Cancer [ICD-11: 2C77] ... | |||||
| Details | It is reported that glucose decrease causes the increase of PSAT1 protein expression compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Glucose decrease (48 hours) | |||||
| Induced Change | PSAT1 mRNA levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Cervical Cancer [ICD-11: 2C77] ... | |||||
| Details | It is reported that glucose decrease causes the increase of PSAT1 mRNA levels compared with control group. | |||||
| Phenylpropanoids and polyketides | ||||||
| Tetracycline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Tetracycline addition (72 hours) | |||||
| Induced Change | PSAT1 protein expression levels: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Acute lymphoblastic leukemia [ICD-11: 2B33] | |||||
| Details | It is reported that tetracycline addition causes the decrease of PSAT1 protein expression compared with control group. | |||||
| References | |||||
|---|---|---|---|---|---|
| 1 | cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Res. 2015 Apr;25(4):429-44. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

